Neurovascular Embolization Devices (Neurology) Market

WEB Devices Emerge as Less-invasive Alternative for Neurovascular Embolization Treatment

Healthcare companies in the neurovascular embolization devices (neurology) market have successfully established a strong foundation for treatment options with the help of embolization coils and liquid embolic systems. However, these treatment options present unique challenges in certain health conditions such as wide-neck bifurcated aneurysms. To overcome this challenge, manufacturers are introducing single-treatment saccular implants. Based on the same principle, healthcare companies in the neurovascular embolization devices (neurology) market are developing Woven EndoBridge (WEB) aneurysm embolization systems that overcome the complications associated with coil-assist devices and surgical clippings.

WEB devices are gaining prominence as a less-invasive treatment alternative for wide-neck intracranial aneurysms in the neurovascular embolization devices (neurology) market space. This is why, many healthcare companies are investing in WEB devices and seeking the approval of health commissions. For instance, in January 2019, MicroVention — a neuroendovascular medical device company, announced the launch of an FDA-approved WEB aneurysm embolization system for the treatment of wide-neck bifurcated aneurysms.

Request the Coronavirus Impact Analysis on this Markets -  https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=73906

Get a glimpse of the in-depth analysis through our Report Brochure

Healthcare Companies Scale Market Growth with Flow-diverting Devices

Recent advances in device technology are more focused on the control and precision of device placement during deployment procedures. To achieve this, healthcare companies in the neurovascular embolization devices (neurology) market are innovating in flow diversion technology. This is evident, as among the products in the neurovascular embolization devices (neurology) market, flow diversion stents are estimated to have the second-highest revenue of ~US$ 215 million by 2027.

Flow diversion technology has triggered the need for improved devices in the neurovascular embolization devices (neurology) landscape. As such, manufacturers are increasing the availability of flow-diverting devices for use in hospitals and ambulatory surgical centers. However, flow-diverting devices lead to challenging complications such as vertebrobasilar aneurysms in patients. Thus, healthcare companies are overcoming this limitation by seeking licensed approval from health commissions, so that their devices are credible. They are increasing research & development to validate clinically-approved data on the long-term benefits of using flow-diverting devices.

To know the scope of our report Get a Sample on Neurovascular Embolization Devices (Neurology) Market 

PED and Pipeline Flex: Reliable Treatment Options for Bifurcation Aneurysms

Although flow diversion stents result in fewer complications in patients, lack of clinical evidence about their long-term outcome remains a matter of debate. This is why, healthcare companies in the neurovascular embolization devices (neurology) market are supporting the treatment infrastructure with pipeline embolization devices (PEDs). Since these devices are outperforming other endoluminal devices, manufacturers are promoting their application for bifurcation aneurysms.

Posterior circulation aneurysm is another driver that is demanding the need for PEDs in the neurovascular embolization devices (neurology) market. As such, manufacturers are introducing variations in braided stents, local porosity, and filament position modeled with cone beam computed tomography to provide critical information to healthcare providers, prior to surgical treatments. PED technology is being rapidly transformed into pipeline flex technology. Although limited studies prove its long-term outcomes, pipeline flex is found to be a safe treatment option, and it serves as a short-term efficacy alternative.

Expanding operations in future? To get the perfect launch ask for a custom report

More Trending Reports by Transparency Market Research  – https://www.biospace.com/article/diabetic-foot-ulcers-treatment-market-surge-in-number-of-amputations-due-to-diabetic-foot-ulcers-to-propel-the-market/

About This Author

monali Joined: April 13th, 2018